Literature DB >> 29744559

Chronic kidney disease-induced atrial structural remodeling and atrial fibrillation: more studies on the pathological mechanism are encouraged.

Huiliang Qiu1,2, Chunlan Ji3,4, Huanlin Wu3,5,6, Chuan Zou7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29744559     DOI： 10.1007/s00210-018-1494-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  14 in total

Review 1.  Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?

Authors:  Jordi Heijman; Niels Voigt; Shokoufeh Ghezelbash; Ilona Schirmer; Dobromir Dobrev
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

2.  Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.

Authors:  Jo-Nan Liao; Tze-Fan Chao; Chia-Jen Liu; Kang-Ling Wang; Su-Jung Chen; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Fa-Po Chung; Tzeng-Ji Chen; Shih-Ann Chen
Journal:  Kidney Int       Date:  2015-01-14       Impact factor: 10.612

Review 3.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

4.  Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.

Authors:  Oliver Adam; Daniel Lavall; Katharina Theobald; Mathias Hohl; Markus Grube; Sabine Ameling; Mark A Sussman; Stephan Rosenkranz; Heyo K Kroemer; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 24.094

5.  Requirement of Rac1 in the development of cardiac hypertrophy.

Authors:  Minoru Satoh; Hisakazu Ogita; Kyosuke Takeshita; Yasushi Mukai; David J Kwiatkowski; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

6.  The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.

Authors:  Wei-Ta Chen; Yao-Chang Chen; Ming-Hsiung Hsieh; Shih-Yu Huang; Yu-Hsun Kao; Yi-Ann Chen; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Cardiovasc Electrophysiol       Date:  2014-11-04

7.  Redox and Activation of Protein Kinase A Dysregulates Calcium Homeostasis in Pulmonary Vein Cardiomyocytes of Chronic Kidney Disease.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Ming-Hsiung Hsieh; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Am Heart Assoc       Date:  2017-07-12       Impact factor: 5.501

8.  Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.

Authors:  Kohei Aoki; Yasushi Teshima; Hidekazu Kondo; Shotaro Saito; Akira Fukui; Naoya Fukunaga; Tomoko Nawata; Tatsuo Shimada; Naohiko Takahashi; Hirotaka Shibata
Journal:  J Am Heart Assoc       Date:  2015-10-09       Impact factor: 5.501

9.  Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation.

Authors:  Guixin He; Wei Tan; Bingjian Wang; Jianzhou Chen; Guannan Li; Suhui Zhu; Jun Xie; Biao Xu
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease.

Authors:  Li-Han Chin; Yu-Juei Hsu; Shih-Che Hsu; Yen-Hui Chen; Yung-Lung Chang; Shih-Ming Huang; Chien-Sung Tsai; Chih-Yuan Lin
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.